AMBEV S.A. current report, Q4 FY2024

Business Context and Reporting Period

This Form 6-K filing by Ambev S.A. covers the period from October 1 to October 31, 2024. The report discloses consolidated transactions of securities and derivatives involving the company's Board of Directors, Management, and Fiscal Council, in compliance with Article 11 of CVM Instruction #358/2002. The filing was signed on November 7, 2024.

Key Financial Metrics

The filing does not provide consolidated financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It strictly reports on insider trading activity.

Group Transaction Type Quantity Average Price (R$) Total Volume (R$)
Board of Directors Sell 55,603 13.58 755,088.74
Management Sell 85,000 13.14 1,113,550.00
Fiscal Council None 0 - 0.00

Note: Management transactions consisted of two separate sales: 30,000 shares at R$13.56 and 55,000 shares at R$12.85.

Material Changes

The filing details a reduction in shareholdings for the Board of Directors and Management groups during October 2024. No acquisitions were reported for these groups. The Fiscal Council held no shares and reported no transactions.

Guidance, Outlook, and Risks

The filing text does not provide management commentary, financial guidance, outlook, risk factors, or contingencies. It is a regulatory disclosure of specific securities transactions only.

Investor Verification Checklist

  • Verify the total volume of shares sold by insiders (140,603 shares) against the company's total outstanding share count to assess dilution or sentiment impact.
  • Confirm the trading dates (October 1 and October 15) to ensure transactions occurred outside of any potential blackout periods.
  • Review the price variance in Management sales (R$13.56 vs R$12.85) to understand market conditions during the transaction window.
  • Check subsequent filings for any changes in the "Final Balance" positions reported here.